127 related articles for article (PubMed ID: 2900598)
21. Potential histamine H2-receptor antagonists: ranitidine analogues containing "semicarbazono equivalent" groups.
Sorba G; Fruttero R; Calvino R; Gasco A; Orsetti M
Arch Pharm (Weinheim); 1984 Jun; 317(6):496-501. PubMed ID: 6148051
[No Abstract] [Full Text] [Related]
22. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacology of two new histamine receptor antagonists related to ranitidine.
Navarro JJ; Almeida JF; Anaya J; Moran JR; Grande M; Caballero MC; Palacios B; Montero MJ; San Roman L
Pharmazie; 1995 Jan; 50(1):12-5. PubMed ID: 7886119
[TBL] [Abstract][Full Text] [Related]
24. Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle.
Bertaccini G; Coruzzi G
Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):225-7. PubMed ID: 6119622
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
26. SAR studies on H2 antagonists containing alkylamino substituted 1,2, 5-thiadiazole 1-oxide moieties.
Di Stilo A; Cena C; Lolli M; Sorba G; Gasco A; Bertaccini G; Pozzoli C; Adami M; Coruzzi G
Farmaco; 1998; 53(8-9):536-40. PubMed ID: 10081815
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
[TBL] [Abstract][Full Text] [Related]
28. Action of the new H2-antagonist, DA 4577, on different in vitro and in vivo preparations.
Bertaccini G; Poli E; Coruzzi G
Agents Actions; 1984 Apr; 14(3-4):510-5. PubMed ID: 6145337
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
30. 5-Aminobenzimidazole inhibits gastric acid secretion in Shay-rats.
Trivulzio S; Colombo R; Rossoni G; Caironi E
Pharmacol Res Commun; 1988 Nov; 20(11):975-82. PubMed ID: 3241822
[TBL] [Abstract][Full Text] [Related]
31. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
32. Effects of 2-guanidine-4-methylquinazoline on gastric acid secretion in rats.
Pinelli A; Trivulzio S; Pojaga G; Rossoni G
Pharmacol Res; 1996; 34(5-6):225-30. PubMed ID: 9076847
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of a new peptidic gastrin antagonist.
Lavezzo A; Bali JP; Magous R; Lignon MF; Nisato D; Laur J; Castro B; Martinez J
Regul Pept; 1986 Sep; 15(2):111-9. PubMed ID: 3786833
[TBL] [Abstract][Full Text] [Related]
35. 1,2,5-thiadiazole 1-oxide and 1,1-dioxide derivatives. A new class of potent histamine H2-receptor antagonists.
Algieri AA; Luke GM; Standridge RT; Brown M; Partyka RA; Crenshaw RR
J Med Chem; 1982 Mar; 25(3):210-2. PubMed ID: 6121914
[No Abstract] [Full Text] [Related]
36. Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties.
Coruzzi G; Adami M; Morini G; Pozzoli C; Cena C; Bertinaria M; Gasco A
J Physiol Paris; 2000; 94(1):5-10. PubMed ID: 10761682
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of the novel H2 antagonist famotidine: in vitro studies.
Bertaccini G; Coruzzi G; Poli E; Adami M
Agents Actions; 1986 Nov; 19(3-4):180-7. PubMed ID: 2881455
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 2-imidazolidinylidene propanedinitrile derivatives as stimulators of gastrointestinal motility--III.
Sasho S; Obase H; Ichikawa S; Kitazawa T; Nonaka H; Yoshizaki R; Ishii A; Shuto K
Bioorg Med Chem; 1995 Mar; 3(3):279-87. PubMed ID: 7606389
[TBL] [Abstract][Full Text] [Related]
39. Evidence of H3 receptor inhibition by iodoaminopotentidine in the guinea pig ileum.
Hemedah M; Mitchelson FJ; Coupar IM
Life Sci; 1998; 63(15):1371-6. PubMed ID: 9768875
[TBL] [Abstract][Full Text] [Related]
40. Histamine H2-antagonists--past, present and future.
Brittain RT; Jack D
J Clin Gastroenterol; 1983; 5 Suppl 1():71-9. PubMed ID: 6140285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
